Erratum to: Improved Pharmacokinetic and Biodistribution Properties of the Selective Urokinase Inhibitor PAI-2 (SerpinB2) by Site-Specific PEGylation: Implications for Drug Delivery.

Pharm Res

School of Biological Sciences, Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, 2522, Australia.

Published: August 2015

Download full-text PDF	Source
http://dx.doi.org/10.1007/s11095-015-1735-x	DOI Listing

Publication Analysis

erratum improved

improved pharmacokinetic

pharmacokinetic biodistribution

biodistribution properties

properties selective

selective urokinase

urokinase inhibitor

inhibitor pai-2

pai-2 serpinb2

serpinb2 site-specific

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!